Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism

Clinical trial NCT06140095 · UNKNOWN

Trial details

NCT number: NCT06140095
Sponsor: Region Stockholm
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Metabolic Effects of Evolocumab and Atorvastatin

Start date: 2024-02-01
Primary completion: 2025-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.